Patents by Inventor Jack Cardinal

Jack Cardinal has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 9060941
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: June 23, 2015
    Assignees: ACTAVIS, INC., TAKEDA PHARMACEUTICAL COMPANY LIMITED
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Patent number: 8084058
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.
    Type: Grant
    Filed: March 30, 2005
    Date of Patent: December 27, 2011
    Assignees: Watson Pharmaceuticals, Inc., Takeda Pharmaceutical, Co. Ltd.
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia
  • Dosage form holder device and methods for immersion testing
    Publication number: 20070209455
    Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
    Type: Application
    Filed: May 10, 2007
    Publication date: September 13, 2007
    Inventors: D. Tian, Xiu Cheng, Jack Cardinal, Boyong Li, Avinash Nangia
  • Dosage form holder device and methods for immersion testing
    Patent number: 7237436
    Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: July 3, 2007
    Inventors: Dacheng Tian, Xiu Xiu Cheng, Jack Cardinal, Boyong Li, Avinash Nangia
  • Dosage form holder device and methods for immersion testing
    Publication number: 20060207356
    Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
    Type: Application
    Filed: March 20, 2006
    Publication date: September 21, 2006
    Inventors: Dacheng Tian, Xiu Cheng, Jack Cardinal, Boyong Li, Avinash Nangia
  • Dosage form holder device and methods for immersion testing
    Patent number: 7051606
    Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
    Type: Grant
    Filed: January 30, 2004
    Date of Patent: May 30, 2006
    Assignee: Andrx Labs LLC
    Inventors: Dacheng Tian, Xiu Xiu Cheng, Jack Cardinal, Boyong Li, Avinash Nangia
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20050249809
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative and a disintegrating agent is herein disclosed and described. The dosage formulation exhibits a significant increase in bioavailability of the thiazolidinedione derivative component compared to conventional immediate release dosage forms containing only a thiazolidinedione derivative.
    Type: Application
    Filed: March 30, 2005
    Publication date: November 10, 2005
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia
  • Novel pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative
    Publication number: 20050226928
    Abstract: A pharmaceutical dosage form comprising a controlled release component comprising an antihyperglycemic drug in combination with a second component comprising a thiazolidinedione derivative is herein disclosed and described.
    Type: Application
    Filed: March 30, 2005
    Publication date: October 13, 2005
    Inventors: Unchalee Lodin, Jack Cardinal, Avinash Nangia, Kazuhiro Okochi
  • Dosage form holder device and methods for immersion testing
    Publication number: 20050166688
    Abstract: The present invention comprises a device and methods for dissolution or immersion testing and, in particular, a device and methods that improve the consistency of test results by limiting the ability of pharmaceutical or other dosage forms to move or reorient during testing.
    Type: Application
    Filed: January 30, 2004
    Publication date: August 4, 2005
    Inventors: Dacheng Tian, Xiu Cheng, Jack Cardinal, Boyong Li, Avinash Nangia